ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures
NCT00404924
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1140
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Small-Cell Lung Carcinoma
Interventions
DRUG:
ZD6474 (vandetanib)
OTHER:
Best Supportive Care
Sponsor
Genzyme, a Sanofi Company